发明名称 PHARMACEUTICAL COMPOSITION HAVING IMPROVED DISSOLUTION PROFILE FOR POORLY SOLUBLE DRUG
摘要 <P>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition improved in dissolution profiles of drugs therein. <P>SOLUTION: The pharmaceutical compositions comprising an ionizable drug or a salt thereof, a crystallization inhibitor and a pH modifier, and measurably improved in dissolution rate of the ionizable drug are provided. Specifically, there is provided the composition comprising a megluamine salt of 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, a crystallization inhibitor and a pH modifier, and measurably improved in dissolution rate of the ionizable drug. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013121976(A) 申请公布日期 2013.06.20
申请号 JP20130018095 申请日期 2013.02.01
申请人 ABBOTT LAB 发明人 WU HUAILIANG;ZHANG GEOFF
分类号 A61K31/4709;A61K9/20;A61K9/48;A61K47/02;A61K47/18;A61K47/22;A61K47/26;A61K47/32;A61K47/38 主分类号 A61K31/4709
代理机构 代理人
主权项
地址